Abstract

The step from drug discovery to clinical development is one of the most challenging hurdles, but also one of the most value gaining transformation of a potential drug. The most promising approach is to gain an in-depth understanding of your molecule as well as of the patient population which most likely benefits from treatment. This strategy enables a smart design of a clinical development campaign and contributes to increasing your chances of success.

In this virtual conference representatives from research organizations, Big Pharma and CRO industry will present in-depth compound characterizations covering e.g. target deconvolution, mode of action characterization, biomarker identification, drug repurposing as well as in-depth DMPK and PK-PD understanding. Join the conference to also participate to the discussion panels, at which presenters and audience can exchange on individual perspectives how smart research can smoothen your clinical development path.